Lipids, Statins and Heart Failure: An Update
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
4796-4806
Author(s):
Niki Katsiki, Michael Doumas and Dimitri P. Mikhailidis
Application of Mitochondria-Targeted Pharmaceuticals for the Treatment of Heart Disease
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
4763-4779
Author(s):
Ryan J. Mailloux
Meet the Editorial Board
Journal:
Current Drug Targets
Volume:
17
Page:
1577-1577
Author(s):
Chen Chen
Editorial (Thematic Issue: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Dev elopment (Part C))
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
4337-4340
Author(s):
Mohammad A. Kamal and Nigel H. Greig
Metallothionein as a Scavenger of Free Radicals - New Cardioprotective Therapeutic Agent or Initiator of Tumor Chemoresistance?
Journal:
Current Drug Targets
Volume:
17
Page:
1438-1451
Author(s):
Zbynek Heger, Miguel Angel Merlos Rodrigo, Sona Krizkova, Branislav Ruttkay-Nedecky, Marta Zalewska, Elena Maria Planells del Pozo, Aurelie Pelfrene, Bertrand Pourrut, Marie Stiborova, Tomas Eckschlager, Gabriella Emri, Rene Kizek and Vojtech Adam
Tapping into Mitochondria to Find Novel Targets for Diabetes Complications
Journal:
Current Drug Targets
Volume:
17
Page:
1341-1349
Author(s):
Nicole B. Flemming, Linda A. Gallo, Micheal S. Ward and Josephine M. Forbes
Advanced Glycation End Products: Association with the Pathogenesis of Diseases and the Current Therapeutic Advances
Journal:
Current Clinical Pharmacology
Volume:
11
Page:
118-127
Author(s):
Thekkuttuparambil A. Ajith and Puzhikunathu Vinodkumar
A Review on the Phytochemicals, Ethnomedicine Uses and Pharmacology of Ficus Species
Journal:
Current Traditional Medicine
Volume:
2
Page:
3-17
Author(s):
Chee-Yan Choo and Norakmal Yati Sulong
Diabetes and Complications: Cellular Signaling Pathways, Current Understanding and Targeted Therapies
Journal:
Current Drug Targets
Volume:
17
Page:
1309-1328
Author(s):
Krishna A. Adeshara, Arundhati G. Diwan and Rashmi S. Tupe
FoxO1 Inhibitors: The Future Medicine for Metabolic Disorders?
Journal:
Current Diabetes Reviews
Volume:
12
Page:
223-230
Author(s):
Anuradha Pandey, Goru Santosh Kumar, Almesh Kadakol, Vajir Malek and Anil Bhanudas Gaikwad